From a prior press release:

"At least initially, the revenue from these manual assays marketed in China won’t be comparable to the far greater anticipated revenue to come from Abbott, Inverness and any third licensee. These companies remain BioCurex’s #1 priority."

If Abbott and/or Inverness are no longer interested in RECAF (as some posters keep asserting), why is it Dr. Moro keeps referring to anticipated revenue from Abbott/Inverness/(3rd licensee)? I interpret that as an indication they are still working with RECAF.

Of course, bashers will argue that Dr. Moro is simply lying (or greatly stretching the truth). I don't know Dr. Moro personally (I've only emailed him a couple times in the past), but I've been with BOCX for 4-5 years now, and if I had thought at anytime that he was being dishonest, I'd have gotten out.